JP2009185034A5 - - Google Patents

Download PDF

Info

Publication number
JP2009185034A5
JP2009185034A5 JP2009062262A JP2009062262A JP2009185034A5 JP 2009185034 A5 JP2009185034 A5 JP 2009185034A5 JP 2009062262 A JP2009062262 A JP 2009062262A JP 2009062262 A JP2009062262 A JP 2009062262A JP 2009185034 A5 JP2009185034 A5 JP 2009185034A5
Authority
JP
Japan
Prior art keywords
group
independently
pharmaceutical composition
composition according
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009062262A
Other languages
English (en)
Japanese (ja)
Other versions
JP5270413B2 (ja
JP2009185034A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009185034A publication Critical patent/JP2009185034A/ja
Publication of JP2009185034A5 publication Critical patent/JP2009185034A5/ja
Application granted granted Critical
Publication of JP5270413B2 publication Critical patent/JP5270413B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009062262A 1997-05-27 2009-03-16 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用 Expired - Fee Related JP5270413B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4772497P 1997-05-27 1997-05-27
US60/047,724 1997-05-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP50081799A Division JP4856294B2 (ja) 1997-05-27 1998-05-27 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013003496A Division JP2013121964A (ja) 1997-05-27 2013-01-11 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用

Publications (3)

Publication Number Publication Date
JP2009185034A JP2009185034A (ja) 2009-08-20
JP2009185034A5 true JP2009185034A5 (https=) 2011-10-06
JP5270413B2 JP5270413B2 (ja) 2013-08-21

Family

ID=21950574

Family Applications (3)

Application Number Title Priority Date Filing Date
JP50081799A Expired - Fee Related JP4856294B2 (ja) 1997-05-27 1998-05-27 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用
JP2009062262A Expired - Fee Related JP5270413B2 (ja) 1997-05-27 2009-03-16 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用
JP2013003496A Pending JP2013121964A (ja) 1997-05-27 2013-01-11 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP50081799A Expired - Fee Related JP4856294B2 (ja) 1997-05-27 1998-05-27 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013003496A Pending JP2013121964A (ja) 1997-05-27 2013-01-11 癌の予防および治療処置におけるニトロキシドまたはそのプロドラッグの使用

Country Status (10)

Country Link
EP (1) EP0986393B1 (https=)
JP (3) JP4856294B2 (https=)
AT (1) ATE262330T1 (https=)
AU (1) AU746505B2 (https=)
CA (1) CA2289017C (https=)
DE (1) DE69822626T8 (https=)
DK (1) DK0986393T3 (https=)
ES (1) ES2216286T3 (https=)
PT (1) PT986393E (https=)
WO (1) WO1998053835A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096759A (en) * 1997-09-19 2000-08-01 Georgetown University Method for treating essential hypertension
AU765110B2 (en) * 1998-06-26 2003-09-11 Georgetown University Medical Center Compositions and methods for inducing cell death
US20040219201A1 (en) * 2001-12-06 2004-11-04 Yechezkel Barenholz Tempamine compositions and methods of use
JP2007500227A (ja) * 2003-05-29 2007-01-11 ミトス・ファーマシューティカルズ・インコーポレーテッド 光増感剤及び音増感剤と関連してのニトロキシドの使用方法
WO2006084197A2 (en) * 2005-02-02 2006-08-10 Mitos Pharmaceuticals, Inc. Nitroxides for use in treating or preventing neoplastic disease
US8466130B2 (en) 2009-09-04 2013-06-18 Colby Pharmaceutical Company Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
WO2008109740A2 (en) * 2007-03-06 2008-09-12 Colby Pharmaceutical Company Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
US8853277B2 (en) 2009-11-30 2014-10-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
US10231959B2 (en) 2016-03-23 2019-03-19 Louis Habash Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
JP2019509352A (ja) * 2016-03-23 2019-04-04 ルイス ハバシュ, ヒトの被験物質をニトロキシドで処理することによってapoptosis関連遺伝子の発現レベルを増加させる
US20180078539A1 (en) 2016-03-23 2018-03-22 Louis Habash T-cell regulation in t-cell mediated diseases by reducing pathogenic function of th17 in a human subject through treatment with a nitroxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758580A (en) * 1985-06-26 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Inhibiting growth of tumors with certain substituted phenoxy dimethyl alkanoic acids, esters or salts
DK0462305T3 (da) * 1990-06-21 1995-04-24 Huland Edith Anvendelse af cytokinholdige aerosoler såvel som cytokholdige aerosoler i sig selv
US6605619B1 (en) * 1992-03-20 2003-08-12 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxides as protectors against oxidatives stress
AU4788396A (en) * 1995-02-16 1996-09-04 Children's Medical Center Corporation Inhibition of angiogenesis using interleukin-12

Similar Documents

Publication Publication Date Title
JP2009185034A5 (https=)
JP2015024998A5 (https=)
JP2010530897A5 (https=)
JP2013542261A5 (https=)
JP2012507521A5 (https=)
JP2010001302A5 (https=)
MX2012000959A (es) Inhibidores de los virus flaviviridae.
SG176648A1 (en) Improved method for synthesizing pirfenidone
JP2013510120A5 (https=)
JP2015518055A5 (https=)
BRPI1006115A8 (pt) "agentes indutores de apoptose para o tratamento de câncer e doenças autoimunes".
JP2009516727A5 (https=)
JP2016520618A5 (https=)
TW200833663A (en) Therapeutic agents
JP2010077141A5 (https=)
JP2010527913A5 (https=)
JP2009525981A5 (https=)
JP2013542981A5 (https=)
Hong et al. Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents
JP2016515630A5 (https=)
JP2014502599A5 (https=)
JP2011527678A5 (https=)
JP2016531852A5 (https=)
JP2017505785A5 (https=)
MX2010006108A (es) Inhibidores de estearoil-coa-desaturasa.